Why You Stink as an Investor -- and How to Change That
Mastering this simple concept can make a huge difference in your investment returns.
3 Next-Generation Trends in Medical Tech You Need to Know
From new takes on old technologies to cutting-edge innovations such as robotic surgery and bioprinting, these trends are revolutionizing the future of med tech.
Ask a Fool: What's Your Foolish Opinion on Organovo?
Organovo is up 75% over the past 12 months but has pulled back 15% since the start of 2014. Is this a buy, sell, or hold today?
Organovo Holdings Inc: Did We Learn Anything New From Earnings?
Find out the single most important variable to take away from this bioprinter's release.
The Fool Looks Ahead
Let's look at the stocks that will be making news in the week ahead.
Why Organovo Holdings Shares Vaulted Higher
Organovo shares soared after the company delivered its first 3-D liver tissue product to an outside laboratory. Should shareholders be pumped or primed to run away?
Why Vringo, EZCORP, and Organovo Holdings Are Today's 3 Best Stocks
The S&P 500 gets whacked after another FOMC economic stimulus cut, while Vringo, EZCORP, and Organovo Holdings all rise by double-digits.
Organovo Holdings Inc Reaches Milestone Ahead of Schedule, Stock Pops
This 3-D bioprinter is full of good news for investors today. Here's what it all means.
Can 3D Systems, Voxeljet, and ExOne Bounce Back?
Why did most 3-D printing companies have a rough past week?
It's Time to Stop Worrying and Learn to Love GMOs
Genetically modified food is just one part of the puzzle for nourishing an ever-more-populated world, but its track record is far stronger than most detractors acknowledge.